Glenn Hearson
Jan 20, 2016
Updated: Feb 21, 2023
Completed IPF Study
Multi-Center Study Commercial Clinical Trial to Assess the Efficacy and Safety of GS-6624 in Subjects with Idiopathic Pulmonary Fibrosis.
Principle Investigator: Professor Gisli Jenkins